These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4599458)

  • 1. Prolongation of skin allografts after oral application of ALS in rats.
    Seifert J; Ring J; Brendel W
    Nature; 1974 Jun; 249(459):776. PubMed ID: 4599458
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of skin allograft rejection by post-transplantation administration of specific anti-lymphocyte serum.
    Sundaresan P; Sainis KB; Phondke GP; Sundaram K
    Immunol Lett; 1986 Apr; 12(4):201-5. PubMed ID: 3522415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antilymphocyte serum and lymphatic system. I. The effect of regional administration on the survival of skin allografts.
    Málek P; Kolc J; Hasková V; Zástava V
    Transplantation; 1969 Oct; 8(4):333-7. PubMed ID: 4914422
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of repeated "therapeutic" courses of antilymphocytic globulin administration on skin allograft survival time in rats.
    Andeson NF; Dalton RG
    Transplantation; 1971 Jul; 12(1):54-6. PubMed ID: 4103650
    [No Abstract]   [Full Text] [Related]  

  • 5. Nematospiroides dubius: mechanisms of host immunity. II. Skin testing and immunosuppression of orally or subcutaneously sensitized mice.
    Jones CE
    Exp Parasitol; 1974 Jun; 35(3):453-64. PubMed ID: 4597090
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone.
    Bell PR; Briggs JD; Calman KC; Paton AM; Wood RF; Macpherson SG; Kyle K
    Lancet; 1971 May; 1(7705):876-80. PubMed ID: 4102025
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive properties of corticosteroids. I. Aldosterone as immunosuppressant in skin allograts in rats.
    Baethmann A; Land W; Koczorek KR; Stass P; Brendel W
    Eur Surg Res; 1971; 3(1):40-50. PubMed ID: 4939501
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of rabbit antimouse thymus sera produced after different numbers of injections of lymphoid cells.
    Sutthiwan P; Shorter RG; Hallenbeck GA; Elveback LR
    Transplantation; 1969 Sep; 8(3):249-57. PubMed ID: 4908383
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation of survival of allogeneic skin grafts by L-asparaginase. Preliminary report.
    Hammer C; Brendel W
    Eur Surg Res; 1971; 3(1):72-5. PubMed ID: 4939504
    [No Abstract]   [Full Text] [Related]  

  • 10. Accelerated rejection of skin homografts by vitamin A acid.
    Floersheim GL; Bollag W
    Transplantation; 1972 Nov; 14(5):564-7. PubMed ID: 4563196
    [No Abstract]   [Full Text] [Related]  

  • 11. The tolerogenicity and biological activity of subcellular antigen fractions.
    Cerilli J; Lang RW; Hattan D
    J Surg Res; 1974 Jun; 16(6):565-8. PubMed ID: 4599464
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation of allogeneic transplanted skin grafts by A85 4777, a new immunosuppressive homopiperazine derivative.
    Schorlemmer H; Bartlett RR; Wolf E; Seiler FR
    Transplant Proc; 1990 Aug; 22(4):1671-3. PubMed ID: 2389431
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the efficacy of immunosuppressive regimens on orthotopic heart allografts.
    Kondo Y; Grogan JB; Cockrell JV; Kuramochi T; Smith GV; Hardy JD
    J Thorac Cardiovasc Surg; 1974 Apr; 67(4):612-20. PubMed ID: 4594431
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Prolongation of skin allografts in rats by treatment with linoleic acid.
    Ring J; Seifert J; Mertin J; Brendel W
    Lancet; 1974 Nov; 2(7892):1331. PubMed ID: 4139581
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of allogenic, homozygous bone marrow cells for the induction of specific immunologic tolerance in mice treated with antilymphocyte serum.
    Gozzo JJ; Wood ML; Monaco AP
    Surg Forum; 1970; 21():281-4. PubMed ID: 4936984
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of bacterial adjuvants on allograft survival after anti-lymphocyte serum (ALS) and donor bone marrow in mice.
    Clark AW; Monaco AP
    Immunology; 1974 Nov; 27(5):887-93. PubMed ID: 4373388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperacute rejection of skin allografts in the mouse by the administration of alloantibody and rabbit complement.
    Koene RA; Gerlag PG; Hagemann JF; van Haelst UJ; Wijdeveld PG
    J Immunol; 1973 Aug; 111(2):520-6. PubMed ID: 4577882
    [No Abstract]   [Full Text] [Related]  

  • 18. A lymphocyte cytotoxicity rebound phenomenon induced by enhancing sera.
    Debray-Sachs M; Soucy PE; Hamburger J
    J Immunol; 1973 Mar; 110(3):661-6. PubMed ID: 4569798
    [No Abstract]   [Full Text] [Related]  

  • 19. Route of administration of antilymphocyte serum to mice.
    Shorter RG; Elveback LE
    Transplantation; 1970 Nov; 10(5):435-6. PubMed ID: 4923297
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive properties of corticosteroids. II. Interactions of antilymphocyte serum with corticosteroids in adrenalectomized rats.
    Baethmann A; Kiffner E; Land W; Stass P; Brendel W
    Eur Surg Res; 1971; 3(1):51-61. PubMed ID: 4939502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.